CHI Logo
Shop
Checkout
Header Graphic
August 1, 2010
| Insight Pharma Reports > All Reports
ALL REPORTS

Loading...

Corporate Subscription Program

Insight Pharma Reports has developed and maintained a very impressive and loyal client base, including senior level executives, global competitive intelligence executives, librarians, information specialists, and research scientists.

Click here for more info
Add to Del.icio.us Add to digg Add to Connotea Add to Facebook Add to LinkedIn Add to Twitter EMail Page Printer Friendly Book Mark

2008 Reports:

Loading...

The following reports are published and available for immediate shipment.

 

Please contact Al Doig at adoig@healthtech.com to suggest topics to be updated or new topics to be covered in the area of pharmaceutical drug discovery and development.

Conducting Clinical Trials in Europe: An Insider's Analysis
Conducting Clinical Trials in Europe: An Insider's Analysis
December 2008
Table of Contents | Tables and Figures | Executive Summary

Neurodegenerative Diseases: Next-Generation Drugs for Four Major Disorders
Neurodegenerative Diseases: Next-Generation Drugs for Four Major Disorders
December 2008
Table of Contents | Tables and Figures | Executive Summary

Biomedical Imaging: From Drug Target Discovery to Medical Diagnostics
Biomedical Imaging: From Drug Target Discovery to Medical Diagnostics
December 2008
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Stem Cells Come of Age
Stem Cells Come of Age
November 2008
Table of Contents | Tables and Figures | Executive Summary

Immunotherapies and Vaccines for Cancer and Infectious Diseases
Immunotherapies and Vaccines for Cancer and Infectious Diseases
October 2008
Table of Contents | Tables and Figures | Executive Summary

Kinase Therapeutics Insight Update 2 (August 2008 - September 2008)
Kinase Therapeutics Insight Update 2 (August 2008 - September 2008)
October 2008
GPCRs: Dawn of a New Era?
GPCRs: Dawn of a New Era?
October 2008
Table of Contents | Tables and Figures | Executive Summary

Obesity Drug Pipeline: Developing Therapies for a Complex Disease
Obesity Drug Pipeline: Developing Therapies for a Complex Disease
September 2008
Table of Contents | Tables and Figures | Executive Summary

Kinase Therapeutics Insight Update 1 (April 2008 - July 2008)
Kinase Therapeutics Insight Update 1 (April 2008 - July 2008)
August 2008
Strategic Management of Resources and Portfolios
Strategic Management of Resources and Portfolios
August 2008
Table of Contents | Tables and Figures | Executive Summary

Cancer Biomarkers: Adoption Is Driving Growth
Cancer Biomarkers: Adoption Is Driving Growth
July 2008
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Antibiotic R&D: Resolving the Paradox between Unmet Medical Need and Commercial Incentive
Antibiotic R&D: Resolving the Paradox between Unmet Medical Need and Commercial Incentive
July 2008
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Systems Biology: A Disruptive Technology
Systems Biology: A Disruptive Technology
May 2008
Table of Contents | Tables and Figures | Executive Summary

Blood-Brain Barrier: Bridging Options for Drug Discovery & Development
Blood-Brain Barrier: Bridging Options for Drug Discovery & Development
May 2008
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Cardiotoxicity: Issues, Technologies, and Solutions for the Future
Cardiotoxicity: Issues, Technologies, and Solutions for the Future
May 2008
Table of Contents | Tables and Figures | Executive Summary

Inflammatory Directions: Strategies for Six Diseases with Unmet Needs
Inflammatory Directions: Strategies for Six Diseases with Unmet Needs
April 2008
Table of Contents | Tables and Figures | Executive Summary

MicroRNAs: Commercial Products on the Horizon
MicroRNAs: Commercial Products on the Horizon
March 2008
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Epigenetics: Technologies, Applications, and the Commercial Landscape
Epigenetics: Technologies, Applications, and the Commercial Landscape
February 2008
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Multiplex Assays in Translational Medicine: Technologies, Applications, and Future Directions
Multiplex Assays in Translational Medicine: Technologies, Applications, and Future Directions
February 2008
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Molecular Imaging in Drug R&D and Medical Practice
Molecular Imaging in Drug R&D and Medical Practice
January 2008
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Ophthalmological Therapeutics: Pipelines, Delivery Technologies, and Markets
Ophthalmological Therapeutics: Pipelines, Delivery Technologies, and Markets
January 2008
Table of Contents | Tables and Figures | Executive Summary

2007 Reports
Kinase Therapeutic Pipelines: An Assessment of Targets and Agents in Development
December 2007
Molecular Diagnostics: A Rapidly Shifting Commercial and Technology Landscape
November 2007
Monoclonal Antibodies: Pipeline Analysis and Market Assessment
October 2007
Adaptive Clinical Trials: Innovation in Trial Design, Management, and Analysis
September 2007
Backup Compound Strategies: Best Practices for Reducing Phase II Risk
September 2007
Next-Generation Sequencing: Scientific and Commercial Implications of the $1000 Genome
August 2007
Clinical Forecasting: A Novel Bayesian Tool for Predicting Phase III Outcomes
July 2007
Disease-Related Biomarkers: Their Potential in Patient Screening, Prognosis, and Stratification
June 2007
Diabetes and Its Complications: Strategies to Advance Therapy and Optimize R&D
May 2007
High-Content Analysis: Technologies, Applications, Market Analysis
May 2007
Combination Drug/Diagnostic Products: Pathways to R&D and Commercial Success
May 2007
Metabolic and Inflammatory Disease R&D : An Assessment of 5 Highly Promising Therapeutic Classes
April 2007
Delivery Technologies for Therapeutic Proteins: Assessment and Outlook
March 2007
Cytokine Therapeutics: A Vibrant Pipeline and Active Approved Market
February 2007
Biomarker SOPs: Getting Optimum Value from Your Biomarker Program
January 2007
All Reports 2010 - 2009 - 2008 - 2007 - 2006 - 2005

Cambridge Healthtech Institute

Footer Image
Loading...
  • 250 First Avenue, Suite 300
  • Needham MA 02494
  • phone: 781-972-5400
  • fax: 781-972-5425
  • chi@healthtech.com